Clinical Trials on Epidermylosis Bullosa in Japan
Total 8 results
-
Nihon Pharmaceutical Co., LtdCompleted
-
Nihon Pharmaceutical Co., LtdCompleted
-
Novartis PharmaceuticalsTerminatedBullous PemphigoidTaiwan, Germany, United States, Japan, Austria, France
-
argenxRecruitingBullous PemphigoidNetherlands, Spain, Germany, United Kingdom, China, Italy, Hungary, United States, Croatia, Japan, Serbia, Bulgaria, Israel, Australia, Greece, Slovakia
-
Regeneron PharmaceuticalsSanofiActive, not recruitingBullous PemphigoidUnited States, Japan, Germany, Australia, France, Israel, Poland, Spain, Taiwan
-
AstraZenecaTerminatedBullous PemphigoidFrance, Italy, Spain, Germany, United States, Australia, China, Bulgaria, Israel, Japan, Greece
-
argenxActive, not recruitingBullous PemphigoidUnited States, Australia, Bulgaria, China, Croatia, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Latvia, Netherlands, Poland, Romania, Serbia, Slovakia, Spain, United Kingdom
-
Chugai PharmaceuticalNot yet recruitingAntiphospholipid Syndrome (APS) | Immune Thrombocytopenia (ITP) | Dermatomyositis (DM) | Bullous Pemphigoid (BP) | Behçet's Syndrome (BS) | Immune-mediated Necrotizing Myopathy (IMNM)United States, Japan